July 26, 2010 – A new three-in-one combination drug has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension in patients who do not respond to dual medical treatment. Daiichi Sankyo Inc.
July 26, 2010 – The Centers for Medicare and Medicaid Services (CMS) announced it is soliciting proposals for participation in the Medicare Imaging Demonstration (MID).
July 23, 2010 – For patients suffering from a heart attack, every minute counts, yet the average time from start of chest pain to receiving emergency room (ER) medical attention is 3.2 hours. The average turn-around time of lab-based test results is 2.8 hours, with the minimum time to detect a heart attack using today’s lab-based immunodiagnostics is 4.5 hours from symptom outset.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 23, 2010 - At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus (HIV), two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease (CVD) risk in people with HIV with significant implications for improving medica
July 23, 2010 – A new research and development center for medical imaging systems recently opened at University Hospitals Case Medical Center in northeastern Ohio. The Global Advanced Imaging Innovation Center brings together radiologic experts to coordinate clinical research, education, development and commercialization of advanced imaging technologies.
July 22, 2010 – Changes included in the final rules governing the meaningful use objectives for Medicare and Medicaid incentive programs for electronic health records (EHRs) will improve the odds that more providers can qualify for government stimulus funding.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 22, 2010 – Accumetrics Inc., Daiichi Sankyo Inc., and Eli Lilly and Co. recently announced that they have entered into a strategic collaboration in the United States to raise awareness about antiplatelet therapy and the role of platelet function testing.
July 22, 2010 — Western Maryland Regional Medical Center’s recent upgrade to the newest version of the Impax HeartStation ECG (electrocardiogram) Management System has helped enable the rapid diagnosis and treatment of patients with posterior wall heart attacks.
Cardiac rhythm device reliability and the approach to managing complications associated with these devices have recently been the topic of numerous medical and nonmedical publications.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 21, 2010 – The Advancing Patient Safety Coalition sent a letter to the U.S. Food and Drug Administration earlier this month, urging the agency to immediately issue rules on unique device identification (UDI), which have been three years in the making.
In addition to the FDA-cleared Gore Helex and the AGA Amplatzer transcatheter devices for atrial septal defects (ASDs), there are several others in development or already cleared for use outside the United States.
July 20, 2010 – The final results of the landmark TRUST Trial (Lumax-T/Lumos-T Safely RedUceS RouTine Office Device Follow-up), which show wireless remote monitoring of implantable cardiac devices offers earlier detection of potenial cardiac problems, were published in the July 27 issue of Circulation.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Transcatheter structural heart repair devices deployed in the cath lab have largely replaced open-heart surgery as the therapy of choice. Percutaneously deployed septal occluders make it possible to repair atrial septal defects with better outcomes, fewer complications, faster patient recovery and lower health care costs.
July 20, 2010 — A $5 million loan was granted for the development of a new percutaneous mitral valve repair device.
There is no consensus about whether atherosclerotic renal artery stenosis should be stented or treated medically. There are strong opinions on both sides and clinical data up to now is heavily debated. Many see the trials that could have answered this question as flawed.